• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断检测的卫生技术评估:国际组织方法指南的最新综述。

Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations.

机构信息

York Health Economics Consortium, University of York, York, UK.

Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

Int J Technol Assess Health Care. 2023 Feb 21;39(1):e14. doi: 10.1017/S0266462323000065.

DOI:10.1017/S0266462323000065
PMID:36803886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7614237/
Abstract

OBJECTIVES

To identify which international health technology assessment (HTA) agencies are undertaking evaluations of medical tests, summarize commonalities and differences in methodological approach, and highlight examples of good practice.

METHODS

A methodological review incorporating: systematic identification of HTA guidance documents mentioning evaluation of tests; identification of key contributing organizations and abstraction of approaches to all essential HTA steps; summary of similarities and differences between organizations; and identification of important emergent themes which define the current state of the art and frontiers where further development is needed.

RESULTS

Seven key organizations were identified from 216 screened. The main themes were: elucidation of claims of test benefits; attitude to direct and indirect evidence of clinical effectiveness (including evidence linkage); searching; quality assessment; and health economic evaluation. With the exception of dealing with test accuracy data, approaches were largely based on general approaches to HTA with few test-specific modifications. Elucidation of test claims and attitude to direct and indirect evidence are where we identified the biggest dissimilarities in approach.

CONCLUSIONS

There is consensus on some aspects of HTA of tests, such as dealing with test accuracy, and examples of good practice which HTA organizations new to test evaluation can emulate. The focus on test accuracy contrasts with universal acknowledgment that it is not a sufficient evidence base for test evaluation. There are frontiers where methodological development is urgently required, notably integrating direct and indirect evidence and standardizing approaches to evidence linkage.

摘要

目的

确定哪些国际卫生技术评估(HTA)机构正在对医学检测进行评估,总结方法学方法的异同,并突出良好实践的范例。

方法

采用方法学综述,包括:系统识别提到检测评估的 HTA 指导文件;确定主要参与组织,并提取所有必要的 HTA 步骤的方法;总结组织之间的相似性和差异性;以及确定当前技术现状和需要进一步发展的前沿领域的重要新兴主题。

结果

从 216 篇筛选文献中确定了 7 个关键组织。主要主题包括:阐明检测益处的主张;对临床有效性的直接和间接证据(包括证据链接)的态度;搜索;质量评估;以及健康经济评估。除了处理检测准确性数据外,方法主要基于一般的 HTA 方法,很少有针对检测的具体修改。在检测主张的阐明和对直接和间接证据的态度方面,我们发现方法上存在最大的差异。

结论

在测试评估方面,HTA 有一些方面存在共识,例如处理测试准确性,以及 HTA 机构可以借鉴的良好实践范例。对测试准确性的关注与普遍承认的事实形成对比,即准确性不是测试评估的充分证据基础。在某些方面,方法学发展迫切需要,特别是整合直接和间接证据,并标准化证据链接的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/7ad1060a7faa/S0266462323000065_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/98219296c4bd/S0266462323000065_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/bd2e208e4830/S0266462323000065_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/7ad1060a7faa/S0266462323000065_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/98219296c4bd/S0266462323000065_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/bd2e208e4830/S0266462323000065_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faaa/11574546/7ad1060a7faa/S0266462323000065_fig3.jpg

相似文献

1
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations.诊断检测的卫生技术评估:国际组织方法指南的最新综述。
Int J Technol Assess Health Care. 2023 Feb 21;39(1):e14. doi: 10.1017/S0266462323000065.
2
HTA model for laboratory medicine technologies: overview of approaches adopted in some international agencies.用于实验室医学技术的 HTA 模型:一些国际机构采用方法概述。
Clin Chem Lab Med. 2024 Jul 24;62(10):1928-1937. doi: 10.1515/cclm-2023-1203. Print 2024 Sep 25.
3
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).患者报告结局(PRO)在卫生技术评估(HTA)中的信息价值。
GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.
4
Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges.绘制欧盟联合临床评估与地方卫生技术评估决策之间的方法差距:对部分欧盟市场指南及协调挑战的环境扫描
J Comp Eff Res. 2025 May;14(5):e240240. doi: 10.57264/cer-2024-0240. Epub 2025 Feb 26.
5
Methods of international health technology assessment agencies for economic evaluations--a comparative analysis.国际卫生技术评估机构经济评价方法——比较分析。
BMC Health Serv Res. 2013 Sep 30;13:371. doi: 10.1186/1472-6963-13-371.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations.医疗保健专业人员 HTA 培训:HTA 机构和组织提供的国际计划概述。
Front Public Health. 2022 Feb 10;10:795763. doi: 10.3389/fpubh.2022.795763. eCollection 2022.
8
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia.卫生技术评估机构对肿瘤治疗报销文件中提交的经济评估的评价:来自加拿大、英国和澳大利亚的证据。
Curr Oncol. 2022 Oct 13;29(10):7624-7636. doi: 10.3390/curroncol29100602.
9
Methods for the health technology assessment of complex interventions: A scoping review.复杂干预措施的卫生技术评估方法:一项范围综述
PLoS One. 2025 Mar 14;20(3):e0315381. doi: 10.1371/journal.pone.0315381. eCollection 2025.
10

引用本文的文献

1
Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c.检验医学设备的准确性与有效性之间的关联:运用欧盟卫生技术评估(EUnetHTA)核心模型通过测量糖化血红蛋白(HbA1c)来比较两台分析仪。
Int J Technol Assess Health Care. 2024 Dec 3;40(1):e67. doi: 10.1017/S0266462324000497.
2
Val (EU) xit: do we need an international ISPOR value flower?瓦尔(欧盟)xit:我们需要一朵国际药物经济学与结果研究协会(ISPOR)价值之花吗? (注:这里“xit”不太明确准确含义,可能是特定语境下的特定指代,暂按原样翻译)
J Comp Eff Res. 2024 Sep;13(9):e240083. doi: 10.57264/cer-2024-0083. Epub 2024 Jul 19.
3

本文引用的文献

1
QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies.QUADAS-C:用于评估诊断准确性比较研究偏倚风险的工具。
Ann Intern Med. 2021 Nov;174(11):1592-1599. doi: 10.7326/M21-2234. Epub 2021 Oct 26.
2
Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines.卫生技术评估中的替代终点:方法学指南的国际综述。
Pharmacoeconomics. 2020 Oct;38(10):1055-1070. doi: 10.1007/s40273-020-00935-1.
3
Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
A pilot study investigating severe community-acquired febrile illness through implementation of an innovative microbiological and nucleic acid amplification testing strategy in Timor-Leste (ISIN-MANAS-TL).
一项通过在东帝汶实施创新的微生物学和核酸扩增检测策略(ISIN-MANAS-TL)来调查严重社区获得性发热疾病的试点研究。
IJID Reg. 2024 Mar 10;11:100345. doi: 10.1016/j.ijregi.2024.02.005. eCollection 2024 Jun.
4
Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations.证据综合与链接在诊断测试成本效益模型中的应用:初步良好实践建议。
Appl Health Econ Health Policy. 2024 Mar;22(2):131-144. doi: 10.1007/s40258-023-00855-z. Epub 2024 Feb 5.
5
Future Role of Health Technology Assessment for Genomic Medicine in Oncology: A Canadian Laboratory Perspective.未来肿瘤基因组医学中卫生技术评估的作用:加拿大实验室视角。
Curr Oncol. 2023 Oct 31;30(11):9660-9669. doi: 10.3390/curroncol30110700.
全球卫生技术评估机构对循证审议流程的使用。
Int J Health Policy Manag. 2020 Jan 1;9(1):27-33. doi: 10.15171/ijhpm.2019.72.
4
Methods and reporting of systematic reviews of comparative accuracy were deficient: a methodological survey and proposed guidance.系统评价比较准确性的方法和报告存在缺陷:方法学调查和提出的指导意见。
J Clin Epidemiol. 2020 May;121:1-14. doi: 10.1016/j.jclinepi.2019.12.007. Epub 2019 Dec 14.
5
Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments.为基于模型的诊断试验成本效益评估提供信息的证据综合:卫生技术评估方法学综述
BMC Med Res Methodol. 2017 Apr 14;17(1):56. doi: 10.1186/s12874-017-0331-7.
6
Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests.试验性治疗随机对照试验容易出现偏倚:对评估诊断试验的随机试验方法学质量的综述。
BMC Med Res Methodol. 2017 Feb 24;17(1):35. doi: 10.1186/s12874-016-0287-z.
7
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group.分子诊断的卫生技术评估:医疗器械与诊断特别兴趣小组的实践、挑战与建议
Value Health. 2016 Jul-Aug;19(5):577-87. doi: 10.1016/j.jval.2016.02.012. Epub 2016 May 11.
8
Framework for systematic identification of ethical aspects of healthcare technologies: the SBU approach.医疗技术伦理方面系统识别框架:瑞典国家卫生和福利委员会方法
Int J Technol Assess Health Care. 2015 Jan;31(3):124-30. doi: 10.1017/S0266462315000264.
9
Health technology assessment of medical devices: a survey of non-European union agencies.医疗器械的卫生技术评估:对非欧盟机构的一项调查
Int J Technol Assess Health Care. 2015 Jan;31(3):154-65. doi: 10.1017/S0266462315000185. Epub 2015 Jun 5.
10
The "linked evidence approach" to assess medical tests: a critical analysis.评估医学检测的“关联证据方法”:批判性分析。
Int J Technol Assess Health Care. 2013 Jul;29(3):343-50. doi: 10.1017/S0266462313000287. Epub 2013 Jun 17.